Efficacy And Safety Of Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination In Patients With Moderate To Severe COPD, Stratified By COPD Severity

被引：0
|
作者：
D'Urzo, A. [1 ]
Singh, S. D. [2 ]
Kerwin, E. M. [3 ]
Lakkis, H. [4 ]
Chuecos, F. [5 ]
De Miquel, G. [5 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Univ Manchester, Manchester, Lancs, England
[3] Clin Res Inst, Medford, MA USA
[4] Forest Res Inst, Jersey City, NJ USA
[5] AstraZeneca Plc, Barcelona, Spain
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2015年 / 191卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5783
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Evaluation of the Efficacy and Safety of Two Doses of Aclidinium and Formoterol in Fixed-Dose Combination in Patients With COPD: The ACLIFORM Study
    Singh, Dave
    Jones, Paul
    Bateman, Eric
    Korn, Stephanie
    Serra, Cristina
    Molins, Eduard
    Caracta, Cynthia
    Gil, Esther Garcia
    Leselbaum, Anne
    CHEST, 2014, 145 (03)
  • [22] Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study
    Singh, Dave
    Jones, Paul W.
    Bateman, Eric D.
    Korn, Stephanie
    Serra, Cristina
    Molins, Eduard
    Caracta, Cynthia
    Gil, Esther Garcia
    Leselbaum, Anne
    BMC PULMONARY MEDICINE, 2014, 14
  • [23] Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study
    Dave Singh
    Paul W Jones
    Eric D Bateman
    Stephanie Korn
    Cristina Serra
    Eduard Molins
    Cynthia Caracta
    Esther Garcia Gil
    Anne Leselbaum
    BMC Pulmonary Medicine, 14
  • [24] Efficacy and tolerability of aclidinium bromide/fomoterol fumarate fixed-dose combination in patients with COPD: A 1-year study
    Make, Barry
    Donohue, James
    Soong, Weily
    Zhong, Xiaoyun
    Leselbaum, Anne
    Caracta, Cynthia
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [25] Long-term safety of aclidinium bromide/formoterol fumarate fixed-dose combination: Results of a randomized 1-year trial in patients with COPD
    Donohue, James F.
    Soong, Weily
    Wu, Xiao
    Shrestha, Pomy
    Lei, Alejhandra
    RESPIRATORY MEDICINE, 2016, 116 : 41 - 48
  • [26] Overall And Cardiovascular Safety Of Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination (fdc) In COPD: Pooled Analyses Of Four Phase Iii Studies
    Donohue, J. F.
    D'Urzo, A. D.
    Korn, S.
    Shrestha, P.
    Lei, A.
    Garcia Gil, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [27] Effect of aclidinium bromide/formoterol fumarate fixed-dose combination (FDC) on night-time and early morning symptoms in COPD
    Singh, Dave
    Chapman, Kenneth
    Make, Barry
    Mocarski, Michelle
    Serra, Cristina
    Gil, Esther Garcia
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [28] Overall and cardiovascular safety of aclidinium/formoterol fixed-dose combination versus salmeterol/fluticasone in patients with COPD
    Beier, Jutta
    Vogelmeier, Claus
    Mroz, Robert
    Pascual, Sergi
    Maria Segarra, Rosa
    Lei, Alejhandra
    De Miquel, Gonzalo
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [29] Comparative efficacy and safety of glycopyrronium/formoterol fixed-dose combination versus glycopyrronium monotherapy in patients with moderate-to-severe COPD
    Salvi, Sundeep
    Jain, Manish K.
    Krishnamurthy, Srikanth
    Balki, Akash
    Kodgule, Rahul
    Tandon, Monika
    Bhagat, Sagar
    Panchal, Sagar
    Khatri, Nishtha
    Wu, Wen
    Pendse, Amol
    Patil, Saiprasad
    Barkate, Hanmant
    LUNG INDIA, 2022, 39 (06) : 517 - 524
  • [30] Safety of aclidinium bromide/formoterol fumarate fixed dose combination (FDC) in COPD: Pooled analyses of three phase III studies
    Korn, Stephanie
    Kerwin, Edward
    Donohue, James F.
    Shrestha, Pomy
    Leselbaum, Anne
    Lei, Alejhandra
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
12345